Managing Your Care
619 articles
Family History Matters
After Martin Abrams lost two siblings to pancreatic cancer, he made sure he was screened regularly because of his family history.
Going Outside Standard Protocol Changed Everything
Sharon Rockmaker was determined to have a Whipple procedure despite having stage IV pancreatic cancer, and she finally did.
BRCA Mutation Determines My Pancreatic Cancer Treatment
Chris Treubert started with one type of chemotherapy but when the results of genetic testing showed a BRCA mutation he changed treatment.
Choosing the Right Doctor
Rita Krueger made an important decision that changed her pancreatic cancer treatment when she got a second opinion.
Vigilance Leads to Pancreatic Cancer Diagnosis
After his pancreatic cancer diagnosis, Michael Whalen searched for someone willing to treat him with chemotherapy.
A Clinical Trial Gives Me Hope
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.
Why You Need This Simple Blood Test at Diagnosis
An important factor in determining which treatment to use for pancreatic cancer patients is measuring the level of tumor marker CA-19-9. Learn more here.
New Drug Shows Positive Results in Early Trials
A new drug called PEGPH20, which helps chemotherapy drugs reach their target, is showing positive results in an ongoing pancreatic cancer trial.
Precision Promise Places Patients at Center of Research
Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.
Testing Vitamin C as a Cancer Killer
Lewis Cantley’s team is starting clinical trials of vitamin C to gain more information about its role in stopping cancer.
Predicting Effective Therapy in Pancreatic Cancer
Dr. Kenneth Yu is leading a clinical trial that looks at a pancreatic cancer patient’s pharmacogenomic profile, to see which chemotherapy works better.
A Simple Blood Test for Early Detection of Eight Cancers Shows Promise
Dr. Anne Marie Lennon explains the CancerSEEK blood test, a liquid biopsy in clinical trials for early detection of eight cancers, including pancreatic.
Collaborative Multi-Center Immunotherapy Trial Targets CD40 and PD-1
Dr. Mark O’Hara outlines a collaborative clinical trial of two immunotherapy agents–a checkpoint inhibitor and a monoclonal antibody–plus standard chemotherapy.
Multicenter Trial Focuses on Neoadjuvant Treatment for Borderline Resectable and Locally Advanced Disease
Dr. David Ryan outlines a new trial for pre-surgical pancreatic cancer treatment combining a blood pressure drug, immunotherapy, standard care and SBRT.
Man + Machine: Using Deep Learning for Early Detection of Pancreatic Cancer
Dr. Elliot Fishman is part of a team that is using artificial intelligence, or deep learning to develop techniques for early detection of pancreatic cancer.